- Corporate Officers - D
- Dupont Jakob
Insider Trading History of Dupont Jakob
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dupont Jakob since 1.
This trader's CIK number is 1553335.
At the time of last reporting, Dupont Jakob was the EVP, Head of R&D of Atara Biotherapeutics, Inc.. (stock ticker symbol ATRA).
Also see all insider trading activities at Atara Biotherapeutics, Inc..
Note that in the past
Dupont Jakob also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Gossamer Bio, Inc. (GOSS) by Dupont Jakob
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | GOSS | 0 | $0 | 41,994 | $631,535 | 41,994 | $449,755 |
| 2019 | GOSS | 0 | $0 | 41,994 | $631,535 | 41,994 | $449,755 |
Yearly summary of insider trading at Oncomed Pharmaceuticals Inc (OMED) by Dupont Jakob
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | OMED | 0 | $0 | 4,662 | $97,410 | 2,500 | $11,399 |
| 2015 | OMED | 0 | $0 | 31,000 | $691,704 | 31,000 | $141,350 |
| 2014 | OMED | 0 | $0 | 3,000 | $69,003 | 3,000 | $13,678 |
Yearly summary of insider trading at Atara Biotherapeutics, Inc. (ATRA) by Dupont Jakob
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ATRA | 0 | $0 | 5,074 | $18,403 | 0 | $0 |
| 2022 | ATRA | 0 | $0 | 19,560 | $162,795 | 5,000 | $47,900 |
| 2021 | ATRA | 0 | $0 | 14,351 | $236,348 | 10,000 | $95,800 |
Insider trading activities at 3 companies by Dupont Jakob:
1. Gossamer Bio, Inc. (GOSS)
2. Oncomed Pharmaceuticals Inc (OMED)
3. Atara Biotherapeutics, Inc. (ATRA)
Table 1. Insider trading of Gossamer Bio, Inc. (GOSS) by Dupont Jakob
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-12-27 | GOSS | Option Ex | 1,994 | 10.71 | 21,355 |
| 2019-12-27 | GOSS | Sale | 1,994 | 15.81 | 31,535 |
| 2019-12-30 | GOSS | Sale | 40,000 | 15.00 | 600,000 |
| 2019-12-30 | GOSS | Option Ex | 40,000 | 10.71 | 428,400 |
| 2019-12-30 | GOSS | Sale | 40,000 | 15.00 | 600,000 |
| 2019-12-27 | GOSS | Sale | 1,994 | 15.81 | 31,535 |
| 2019-12-30 | GOSS | Option Ex | 40,000 | 10.71 | 428,400 |
| 2019-12-27 | GOSS | Option Ex | 1,994 | 10.71 | 21,355 |
Table 2. Insider trading of Oncomed Pharmaceuticals Inc (OMED) by Dupont Jakob
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-11 | OMED | Option Ex | 2,500 | 4.56 | 11,399 |
| 2016-01-11 | OMED | Sale | 2,500 | 20.01 | 50,020 |
| 2016-01-06 | OMED | Sale | 2,161 | 21.92 | 47,369 |
| 2016-01-07 | OMED | Sale | 1 | 21.33 | 21 |
| 2015-12-10 | OMED | Sale | 2,500 | 20.49 | 51,232 |
| 2015-12-10 | OMED | Option Ex | 2,500 | 4.56 | 11,399 |
| 2015-11-10 | OMED | Option Ex | 2,500 | 4.56 | 11,399 |
| 2015-11-10 | OMED | Sale | 2,500 | 21.17 | 52,922 |
| 2015-10-26 | OMED | Option Ex | 5,000 | 4.56 | 22,799 |
| 2015-10-26 | OMED | Sale | 5,000 | 20.00 | 100,000 |
| 2015-08-10 | OMED | Sale | 2,500 | 22.25 | 55,622 |
| 2015-08-10 | OMED | Option Ex | 2,500 | 4.56 | 11,399 |
| 2015-07-10 | OMED | Option Ex | 2,500 | 4.56 | 11,399 |
| 2015-07-10 | OMED | Sale | 2,500 | 20.13 | 50,325 |
| 2015-07-06 | OMED | Option Ex | 2,500 | 4.56 | 11,399 |
| 2015-07-06 | OMED | Sale | 2,500 | 21.22 | 53,050 |
| 2015-04-10 | OMED | Sale | 1,500 | 26.51 | 39,765 |
| 2015-04-10 | OMED | Option Ex | 1,500 | 4.56 | 6,839 |
| 2015-03-10 | OMED | Sale | 1,500 | 27.17 | 40,753 |
| 2015-03-10 | OMED | Option Ex | 1,500 | 4.56 | 6,839 |
| 2015-02-10 | OMED | Option Ex | 1,500 | 4.56 | 6,839 |
| 2015-02-10 | OMED | Sale | 1,500 | 24.23 | 36,351 |
| 2015-01-12 | OMED | Option Ex | 1,500 | 4.56 | 6,839 |
| 2015-01-12 | OMED | Sale | 1,500 | 26.12 | 39,184 |
| 2015-01-05 | OMED | Sale | 7,500 | 23.00 | 172,500 |
| 2015-01-05 | OMED | Option Ex | 7,500 | 4.56 | 34,200 |
| 2014-07-23 | OMED | Sale | 1,500 | 23.00 | 34,500 |
| 2014-07-23 | OMED | Option Ex | 1,500 | 4.56 | 6,839 |
| 2014-06-26 | OMED | Sale | 1,500 | 23.00 | 34,503 |
| 2014-06-26 | OMED | Option Ex | 1,500 | 4.56 | 6,839 |
Table 3. Insider trading of Atara Biotherapeutics, Inc. (ATRA) by Dupont Jakob
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-03-02 | ATRA | Sale | 5,074 | 3.63 | 18,403 |
| 2022-11-16 | ATRA | Sale | 4,342 | 4.49 | 19,499 |
| 2022-08-16 | ATRA | Sale | 4,124 | 5.03 | 20,760 |
| 2022-05-17 | ATRA | Sale | 3,873 | 5.32 | 20,596 |
| 2022-03-01 | ATRA | Sale | 2,221 | 9.86 | 21,890 |
| 2022-01-03 | ATRA | Sale | 5,000 | 16.01 | 80,050 |
| 2022-01-03 | ATRA | Option Ex | 5,000 | 9.58 | 47,900 |
| 2021-12-01 | ATRA | Option Ex | 5,000 | 9.58 | 47,900 |
| 2021-12-01 | ATRA | Sale | 5,000 | 17.94 | 89,690 |
| 2021-11-16 | ATRA | Sale | 2,199 | 17.12 | 37,640 |
| 2021-11-02 | ATRA | Sale | 5,000 | 16.41 | 82,050 |
| 2021-11-02 | ATRA | Option Ex | 5,000 | 9.58 | 47,900 |
| 2021-08-17 | ATRA | Sale | 2,152 | 12.53 | 26,968 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Dupont Jakob
(EVP, Head of R&D of Atara Biotherapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.